COMPUTER ASSISTED PATIENT INTERVIEWING IN CLINICAL PHARMACY

临床药师应对药物信息爆炸， 更直接地参与病人护理。 具体来说，临床 药剂师在配药方面变得越来越活跃 向患者提供信息，检查患者对 给药方案、筛选单一药物引起的不良反应 和药物组合，并找出可能的并发症之间 药物和食物，过敏和慢性疾病。 是 充分有效地在这些日益苛刻的任务，药剂师必须 及时了解新药知识，为患者分配更多的时间， 不断提高面试技巧。 为了探索计算机在这些新兴领域的潜在作用， 任务，计算机系统之间的合作项目启动 实验室和临床中心药学部。 因此决定 设计和开发一个可以直接访问病人的计算机系统 为了收集用药史并标记可能的不良反应 与药物治疗有关。 据信，这名“病人” 友好的”系统，如果成功，可以真正“克隆”的技能，临床 药剂师，并允许多个同时面试。 应认识 并不是所有的病人都适合直接用电脑 面试 然而，设计目标是简化计算机 这是一个很好的治疗过程，可以容纳大量的病人。 评价患者和药剂师对初始检测的反应将 在FY91完成。 此外，药物数据的选择和合并 是来年的重要里程碑。

Clinical pharmacists are responding to the drug information explosion by participating more directly in patient care. Specifically, clinical pharmacists have become increasingly active in dispensing pharmaceutical information to patients, checking for patient compliance with their medication regimen, screening for adverse effects caused by single drugs and drug combinations, and sorting out possible complications between medications and food, allergies and chronic medical conditions. To be fully effective in these increasingly demanding tasks, pharmacists must keep abreast of new drug knowledge, allocate more time for patients, and continually sharpen their interviewing skills. In order to explore potential roles of the computer in these emerging tasks, a collaborative project was initiated between the Computer Systems Laboratory and the Clinical Center Pharmacy Department. It was decided to design and develop a computer system that could directly interview patients in order to collect medication histories and flag possible untoward effects related to medication regimens. It is believed that this "patient friendly" system, if successful, could truly "clone" the skills of clinical pharmacists and permit multiple simultaneous interviews. It is recognized that not all patients will be suitable candidates for direct computer interviewing. It is, however, a design objective to simplify the computer interview process so that a large number of patients can be accommodated. Evaluation of patient and pharmacist reactions to the initial testing will be done in FY91. In addition, selection and incorporation of a drug data base are significant milestones for the coming year.